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I was sitting in the chair of the airplane back to Beijing when I
started writing the memoirs to recollect my three journeys to
Western Africa. All of the trips were related to the Ebola
epidemic and covered different stages, from the outbreak
peak to the post-Ebola era. Each journey was taken for a
different task, but all of them represented the urgent and
speciﬁc support from the Chinese Center for Disease Control
and Prevention (China CDC) during the Ebola epidemic in
Western African.
On the August 8th, 2014, the World Health Organization
(WHO) declared the Ebola outbreak in West Africa a Public
Health Emergency of International Concern (PHEIC) (http://
who.int/mediacentre/news/statements/2014/ebola-20140808/
en/). Three days later, together with two colleagues, I was on
the ground of Conakry (Fig. 1), the capital of Guinea, in which
country the ﬁrst Ebola case was traced back to the end of
2013 (Baize et al., 2014).
As the ﬁrst international support force during this epi-
demic, China rapidly reacted to help the three major affected
countries, Guinea, Sierra Leone and Liberia, to ﬁght against
Ebola. Three experts were sent to each of these countries,
respectively, to train the local health workers to use freely
offered sanitary and biological protection supplies. The
training went smoothly under the active cooperation of local
health workers, and the supplies were soon delivered to the
Ebola Treatment Units (ETUs) and the diagnostic laborato-
ries in Guinea. This was the ﬁrst time that China has sent
public health specialists to countries outside of Asia to
support disease control.
In September, 2014, as the Ebola-related support to
Western Africa went deeper, additional Chinese specialists
were sent to Sierra Leone. Clinical treatment teams in ETUs,
Ebola test teams based in a mobile biological safety level 3
laboratory (BSL-3 or P3 lab) and public health training teams
working in the ﬁeld were included. The Deputy Director-
General of the China CDC, Dr. George F. Gao, worked in
Sierra Leone as the co-team leader of the ﬁrst team of the
mobile laboratory for 2 months (Gao and Feng, 2014). He
represented an idol to recruit more young health experts to
work on the ground in Africa (Fig. 2), and I was one of them.
Aside from the mobile laboratory, taking into consideration
a long-term goal to support disease control in Western
Africa, the Chinese government has built the ﬁrst ﬁxed P3
lab in West Africa (Jui, Freetown, Sierra Leone). In the
middle of April, 2015, I came back to Africa with the second
team for the ﬁxed P3 lab, working as the main operator in the
core area for two and a half months. Every time that I opened
specimen packages in the hood, I reminded myself that the
tube in my hand might contain the Ebola virus at a sky-high
titer. Indeed, all of my colleagues recognized that biosafety is
the priority of the laboratory testing for Ebola. During this
period, Ebola virus genomes were quickly assembled and
analyzed by the Chinese deep sequencing platform in
Western Africa (Tong et al., 2015). This platform in the ﬁeld
makes it possible to trace the origin and transmission chain
of the Ebola viruses soon after any new case is reported
(Fig. 3).
With the elapse of new Ebola cases, the Ebola diagnostic
laboratories run on international aid were closed one by one.
In contrast, China CDC strengthened the laboratory work
force to avoid a potential ﬂare-up of the Ebola epidemic.
In the end of 2015, I came back to Freetown as the lead of
the fourth team for the ﬁxed P3 lab to perform Ebola testing
together with nine other Chinese colleagues.
The Ebola surveillance strategy in Sierra Leone was a
community-based swab test of dead individuals, together
with hospital-based blood testing of suspected cases. As
the number of specimens to be tested increased, the
human resources in the laboratory became insufﬁcient.
However, our team accomplished its Ebola testing job and
established good coordination with Dr. Abdul Kamara, who
is the National Laboratory Services Manager of the Min-
istry of Health and Sanitation (MOHS), Sierra Leone
(Fig. 4).
In the end of January, 2016, we have helped to diagnose
the latest and hopefully the last Ebola case in Sierra Leone.
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In the meantime, aside from the swab tests of the dead for
routine Ebola surveillance, the laboratory have taken part in
a project focused on virus persistence in the survivors (Virus
Persistence Study, VPS), collaborating with MOHS of Sierra
Leone, the WHO and U.S. Centers for Disease Control and
Prevention (US-CDC) (Deen et al., 2015). During the post
Ebola era, the proper management and care of the Ebola
survivors is one of the most important tasks for the control of
Ebola. The VPS yielded a good scientiﬁc reference for sur-
vivor counseling, and this project is also a representative
example for international cooperation for disease control in
Africa.
In the post-Ebola era, the international support of public
health to Western Africa should not be diminished but
strengthened. The risk of a ﬂare-up of Ebola still
exists (Wong et al., 2016), considering the unknown
reservoir of Ebola viruses that may persist in animal hosts.
Furthermore, the disease surveillance capacity of many
African countries is yet unbelievable weak, and the risk of
importing yellow fever and Zika virus also exists. Thus,
China CDC quickly reacted to this global health situation
and empowered the ﬁxed P3 lab with the capacity to test
for yellow fever virus and Zika virus in West Africa in
March, 2016.
In addition to the direct support for disease control, the
ﬁxed P3 lab is responsible for training local specialists for
disease control, which is the foundation of long-term support
for Africa. In the past year, several Sierra Leonian specialists
have received training in the laboratory, including theory and
practice in the ﬁxed P3 lab and ﬁeld training in China. They
now work as the team members together with Chinese col-
leagues, which facilitated the establishment of a long-term
co-work strategy in the laboratory. When I was invited to the
wedding of one of my Sierra Leonian colleagues, Mr. Gerald
Bagura, he mentioned that the team in the laboratory worked
like a family (Fig. 5), which was the highest praise for the
teamwork in the ﬁxed P3 lab.
From its commencement in February 2015, the ﬁxed P3
lab has been playing an important role in virus detection and
training the local health workforce. Based on the previous
contribution and the current capacity of the laboratory, the
MOHS of Sierra Leone authorized the designation of the
Figure 1. Training of the local health workers in Guinea to
use the freely offered sanitary and biological protection
supplies from China.
Figure 2. The Deputy Director-General of the China CDC,
Dr. George F. Gao, worked in Sierra Leone as the co-team
leader of the ﬁrst team of the mobile laboratory from
September to November, 2014.
Figure 3. Ebola virus genomes were assembled and ana-
lyzed by the Chinese deep sequencing platform in Free-
town. The lead of the second team, Professor Yuelong Shu
was discussing the sequencing project with the colleagues.
Figure 4. Photograph of Dr. George F. Gao (middle)
with Dr. Abdul Kamara (left) and myself (right) during
Dr. Gao’s second journey to Sierra Leone.
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laboratory as the “National Reference Laboratory for Viral
Hemorrhagic Fevers” and the “National Training Center for
Virus Detection and Biosafety” in the end of June, 2016,
before our team left the country. Dr. Gao was invited back to
Freetown to attend the unveiling ceremony (Fig. 4). He gave
a speech to emphasize the developing orientation of the P3
lab. Dr. Gao also talked with the president of Sierra Leone,
Ernest Bai Koroma, about the possibility for China CDC to
strengthen our support of the research on and pre-warning of
tropical diseases.
Supporting the people of Western Africa during the Ebola
epidemic is the ﬁrst step of the action ‘moving the disease
control frontline onto the “battleﬁeld” anywhere in the world’
of the China CDC. In the future, additional young scientists
and specialists in disease control are needed to work on the
ground of Africa. I am proud to have witnessed this process
and contributed a little based on what I learned over the past
few years. The trip from public health to global health has
just begun.
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